Device Trial Radar · NCT02333864
POGO® Automatic Blood Glucose Monitoring System Clinical Study
Last checked: Nov 20, 2026Latest source record: May 28, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Intuity Medical, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 7, 2015
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if the POGO® system delivers accurate blood glucose readings in the hands of the lay user and assess the POGO® system accuracy when used by trained health care professionals.
Conditions
- Diabetes Mellitus
Interventions
POGO® BGMSDevice
SMBG
Primary outcomes
What the sponsor says the trial is designed to measure.
- Accuracy Validation of the POGO® BGMS: Minimum outcome of 95% of results within 20% of reference measurement.Time frame: Blood glucose measured at time of single visit for each subject, endpoint evaluated at completion of study (approximately four months after initiation.)
1 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Diablo Clinical Reasearch
Walnut Creek, California
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.